[{"Assets_0_FY_USD":344962000.0,"CommonStockSharesOutstanding_0_FY_shares":39719434.0,"EarningsPerShareBasic_1_FY_USD":0.43,"EarningsPerShareDiluted_1_FY_USD":0.4,"NetIncomeLoss_1_FY_USD":17099000.0,"NetIncomeLoss_4_FY_USD":-23177000.0,"StockholdersEquity_0_FY_USD":232846000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_FY_shares":34989218.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_FY_shares":32987335.0,"Ticker":"CRSP","CIK":"1674416","name":"CRISPR THERAPEUTICS AG","OfficialName":"CRISPR Therapeutics AG Common Shares","form":"10-K","period":"20161231","fy":"2016.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4543904930.0","Country":"Switzerland","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20170310"}]